Cabaletta Bio (CABA) Enterprise Value (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Enterprise Value of -$184.2 million for Q4 2025, down 12.35% year-over-year from -$210.2 million in Q4 2024, and down 15.18% quarter-over-quarter from -$159.9 million in Q3 2025.
Cabaletta Bio (CABA) Enterprise Value (2018 - 2026) Analysis & Trends
Cabaletta Bio's Enterprise Value history runs 8 years deep, the most recent figure standing at -$184.2 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 12.35% year-over-year to -$184.2 million; the TTM figure through Dec 2025 stood at -$184.2 million (down 12.35% YoY), while the FY2025 annual figure was -$184.2 million, down 12.35% from the prior year.
- Enterprise Value for Q4 2025 stood at -$184.2 million, down from -$159.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$93.8 million in Q1 2023, with the low at -$272.4 million in Q1 2024.
- The 5-year median for Enterprise Value is -$145.9 million (2025), against an average of -$161.5 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value slumped 190.26% in 2024, then jumped 51.6% in 2025.
- Cabaletta Bio's Enterprise Value stood at -$122.2 million in 2021, then climbed by 12.83% to -$106.5 million in 2022, then sank by 126.42% to -$241.2 million in 2023, then soared by 32.04% to -$164.0 million in 2024, then declined by 12.35% to -$184.2 million in 2025.
- Business Quant data shows CABA's Enterprise Value at -$184.2 million in Q4 2025, -$159.9 million in Q3 2025, and -$243.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | -225.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -225.10 Mn |
| Dec 31, 2025 | -184.22 Mn |
| Sep 30, 2025 | -159.93 Mn |
| Jun 30, 2025 | -243.75 Mn |
| Mar 31, 2025 | -131.83 Mn |
| Dec 31, 2024 | -163.96 Mn |
| Sep 30, 2024 | -195.42 Mn |
| Jun 30, 2024 | -227.84 Mn |
| Mar 31, 2024 | -272.40 Mn |
| Dec 31, 2023 | -241.25 Mn |
| Sep 30, 2023 | -213.28 Mn |
| Jun 30, 2023 | -224.58 Mn |
| Mar 31, 2023 | -93.85 Mn |
| Dec 31, 2022 | -106.55 Mn |
| Sep 30, 2022 | -110.63 Mn |
| Jun 30, 2022 | -96.81 Mn |
| Mar 31, 2022 | -109.21 Mn |
| Dec 31, 2021 | -122.22 Mn |
| Sep 30, 2021 | -119.26 Mn |
| Jun 30, 2021 | -106.12 Mn |